Sermorelin, profile entry
A 29 amino acid GHRH analog that binds the same pituitary receptor as endogenous growth hormone releasing hormone. Triggers a physiologic pulse of growth hormone in the body's own pattern, while the natural negative feedback loop stays intact. Approved branded form discontinued. Modern administration is compounded, prescription only, from US 503A and 503B pharmacies.

Mechanism
Binds pituitary GHRH receptor, triggers pulsatile GH release. Feedback loop preserved.
Dose window
100 to 500 mcg subcutaneous nightly. Most US telehealth protocols sit at 200 to 300 mcg.
Cycle length
12 weeks standard. Re-evaluate IGF-1 at week 12. Off-cycle 4 to 8 weeks if continuing.
Lab markers
IGF-1, fasting glucose, HbA1c, lipids, basic metabolic panel.
Common stack
Sermorelin GHRH plus ipamorelin GHRP for synergistic pulse amplification.
Side effect floor
Injection site redness, transient flush, occasional headache. Hypoglycemia screened.
Adjacent peptides commonly stacked
Sermorelin rarely runs alone in serious protocols. The two adjacent classes worth understanding are GHRPs, which amplify GH pulse amplitude, and longer half-life GHRH analogs, which extend the pulse window. The table below summarizes the field. None of these are sold legally without prescription in the US.

The cycle protocol
A standard 12 week sermorelin run looks like the schedule below. Adjust dose by clinician, not by self-titration. The five-on-two-off cadence reduces tachyphylaxis at the pituitary GHRH receptor over a long cycle.
| Week | Dose | Cadence | Lab check | Notes |
|---|---|---|---|---|
| 1 to 4 | 200 mcg | 5 on, 2 off | Baseline IGF-1 done | Sleep depth shifts first. Hold steady. |
| 5 to 8 | 200 to 300 mcg | 5 on, 2 off | None mid cycle | Skin, hair, energy. Training recovery up. |
| 9 to 12 | 300 mcg | 5 on, 2 off | Follow up IGF-1 at week 12 | Body composition window. Reassess. |
| Week 13 | Pause or maintain | Clinician call | Compare IGF-1 to baseline | Decide hold, lower, or cycle off 4 to 8 weeks. |
Sourcing pathway in the United States
There are two channels for sermorelin in the US. One is legal, clinical, and traceable. The other is not, and is sold under a research-only label that buyers routinely ignore. The difference matters for purity, dose accuracy, and personal legal exposure.

Clinical pathway
Compounded prescription
- Online consultation with a licensed clinician in your state
- Baseline IGF-1 plus metabolic panel ordered
- Prescription dispensed by a 503A or 503B compounding pharmacy
- Sterile vial, accurate concentration, traceable batch
- Sharps kit, dosing protocol, follow-up labs
Research-only pathway
Grey market peptide vendor
- Sold as research chemical, not for human consumption
- No clinician oversight, no prescription, no liability
- Purity and dose vary by batch and supplier
- No medical record, no lab follow-up
- Federal grey area for buyer, frank illegal for some sellers
Not recommended for any adult running protocols seriously.
Self-tracking log, what to measure
Sermorelin works on a slow curve. The signal arrives over weeks, not days, and shows up unevenly across markers. The tracking spec below catches the typical response without over-instrumenting.

Sleep depth, weeks 1 to 4
Wearable deep sleep minutes, subjective restfulness on waking. Most consistent first signal.
Morning energy, weeks 1 to 4
Subjective on a 1 to 10 scale at the same time each morning. Daily, no trend smoothing the first month.
Training recovery, weeks 4 to 8
Time to feel ready for the next session after a hard lift or run. Notes on DOMS duration.
Body composition, weeks 8 to 12
Same day of week, same time of day, same equipment. Waist circumference and weight at minimum. DEXA if possible at baseline and end.
IGF-1, week 12
Follow up draw. Compare to baseline. This is the only objective biochemical signal the protocol moves predictably.
Fasting glucose, monthly
Safety marker. GH downstream can shift insulin sensitivity. Flag any sustained rise.
Sermorelin Peptides therapy in Gates Crossing, MA
Residents of Gates Crossing in Massachusetts have access to compounded Sermorelin Peptides through licensed US telehealth clinicians. Intake is completed online, lab work is drawn at home or at a partner lab, and the medication ships to your address in Gates Crossing.
About Gates Crossing
- State: Massachusetts (MA)
- Population: 40,760
- County: Worcester County
How treatment reaches Gates Crossing
A clinician licensed in Massachusetts reviews your intake and a baseline lab panel. If sermorelin is medically appropriate, a prescription is written to a partner compounding pharmacy that ships directly to your home in Gates Crossing.
Other cities in Massachusetts
- Boston
- South Boston
- Worcester
- Tatnuck
- Springfield
- Brightwood
- East Springfield
- Cambridge
- Lowell
- South Lowell
- Brockton
- New Bedford
- Quincy
- Lynn
- Dorchester
- West Lynn
- East Lynn
- Fall River
- North Fall River
- Newton
Cities near Gates Crossing
Source it through a US licensed clinic
Compounded sermorelin from a registered pharmacy, after a real consultation and lab. Refund if the clinician says no.
View US licensed provider